Skip to main content
Premium Trial:

Request an Annual Quote

DNA Diagnostics Center Acquires Sorenson Subsidiary Identigene

NEW YORK (GenomeWeb) – DNA testing company DNA Diagnostics Center announced today that it has acquired Sorenson Genomics subsidiary Identigene.  

Details of the transaction were not disclosed.

Salt Lake City-based Identigene was established in 2007 and is the first company to offer in-home DNA paternity test collection kits at retail stores in the US, including CVS, Walmart, and Rite Aid. The acquisition includes all of Identigene's assets and laboratory equipment. The business will relocate to DNA Diagnostics' headquarters and laboratory facility in Fairfield, Ohio.

DNA Diagnostics Center offers DNA testing for various applications such as paternity, immigration, family relationships, ancestry, health and beauty, forensics, and animal traits. Its lab is both CAP- and CLIA-accredited.

"We are excited about the acquisition of Identigene," said DNA Diagnostics President and CEO Connie Hallquist in a statement. "They have built a strong brand that consumers trust." 

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.